Related content

Non-inferiority trials in breast and non-small cell lung cancer: Choice of non-inferiority margins and other statistical aspects

By Saad Everardo D.   Buyse Marc  

Acta Oncologica, Vol. 51, Iss. 7, 2012-09 ,pp. : 890-896

Informa Healthcare

Access to resources Recommend Favorite

Non-Inferiority Trials in Surgical Oncology

By Fueglistaler Philipp   Adamina Michel   Guller Ulrich  

Annals of Surgical Oncology, Vol. 14, Iss. 5, 2007-05 ,pp. : 1532-1539

Springer Publishing Company

Access to resources Recommend Favorite

Clinical Trials in Cancer: Principles and Practice

By Perrone F.  

Lancet Oncology, Vol. 4, Iss. 12, 2003-12 ,pp. : 775-775

Elsevier

Access to resources Recommend Favorite

Moving towards molecular-guided treatments: erlotinib and clinical outcomes in non-small-cell lung cancer patients

By Santarpia Mariacarmela   De Pas Tommaso Martino   Altavilla Giuseppe   Spaggiari Lorenzo   Rosell Rafael  

Future Oncology, Vol. 9, Iss. 3, 2013-03 ,pp. : 327-345

Future Medicine

Access to resources Recommend Favorite

A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1

By Sawka C.A.  

Breast Cancer Research and Treatment, Vol. 44, Iss. 3, 1997-07 ,pp. : 211-215

Springer Publishing Company

Access to resources Recommend Favorite